Brain-derived neuro-trophic factor: Began Phase III trial

Amgen Inc. (AMGN), Thousand Oaks, Calif. Product: Brain-derived neuro-trophic factor ( BDNF) Indication: Amyotrophic lateral sclerosis Status: Began Phase III trial ...